Anticoagulant drugs

DRUG3 trials

Sponsors

CHAD, Quovadis Associazione, China National Center for Cardiovascular Diseases

Conditions

Anticoagulants and Bleeding DisordersAtrial FibrillationAtrial Fibrillation (AF)Heart Valve Diseases or ProsthesisVenous Thromboembolism

Early Phase 1

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

RecruitingNCT06615596

China National Center for Cardiovascular DiseasesAtrial Fibrillation (AF)

Start: 2025-08-05End: 2029-12-31Target: 3160Updated: 2026-06-04

Unknown Phase

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

TerminatedNCT03977363

CHADAtrial Fibrillation, Heart Valve Diseases or Prosthesis, Venous Thromboembolism

Start: 2020-01-27End: 2023-03-02Updated: 2023-05-17

MAC Project, Monitoring of AntiCoagulant Therapies (MAC)

CompletedNCT04329390

Quovadis AssociazioneAnticoagulants and Bleeding Disorders

Start: 2019-03-01End: 2024-12-01Updated: 2025-05-07